MHRA details pilot to cut Phase 1 clinical trial review to 14 days by end of 2026
MHRA outlines a staged pilot to reduce first-assessment times for eligible Phase 1 trials in healthy volunteers to 14 days by end-2026, with tight eligibility and limited slots.